Africa Marketing Industry News
SEE OTHER BRANDS

The latest media and advertising news from Africa

AI Tool Projects Risks of Over 1,000 Diseases Up to Two Decades Ahead

(MENAFN) A new artificial intelligence system can forecast an individual’s risk for more than 1,000 diseases, sometimes projecting health outcomes decades into the future, according to a study published Wednesday in the journal Nature.

The study details Delphi-2M, an enhanced language model that uses medical records and lifestyle information to estimate the probability of developing conditions such as cancer, skin diseases, and immune disorders up to 20 years in advance.

Unlike earlier AI tools that focused on predicting single diseases like cancer or cardiovascular issues, Delphi-2M assesses the risk for 1,258 diseases by analyzing a person’s age, sex, body mass index, and habits like smoking and alcohol consumption.

For most diseases, Delphi-2M performed as well or better than existing models that specialize in individual conditions.

The tool was created and tested using anonymized data from 400,000 participants in the UK Biobank and 1.9 million patients recorded in Denmark’s national patient registry.

This advanced AI could transform preventive medicine by helping clinicians identify high-risk patients sooner, allowing for earlier interventions and potentially better health outcomes.

MENAFN21092025000045017169ID1110089166

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions